Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 38Colorectal Neoplasms 18Stomach Neoplasms 7Biliary Tract Neoplasms 5Rectal Neoplasms 3Neoplasm Metastasis 3Cholangiocarcinoma 3Neoplasms 2Metastatic Pancreatic Adenocarcinoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Wilms Tumor 1Weight Loss 1Triple Negative Breast Neoplasms 1Small Bowel Adenocarcinoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Rectal Cancer Patients 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pancreatic cancer, adult 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Diseases 1Pancreatic Cancer Non-resectable 1Pancreatic Cancer Metastatic to Liver 1Pancreatic Adenocarcinoma 1PDAC - Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1

Interventions

Capecitabine 2irinotecan sucrosofate 1Immunotherapy 1Folfox protocol 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Rectal Cancer × irinotecan sucrosofate × Gastrointestinal × Clear all
NCT07281157 2026-06-03

Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡